Inventor · disambiguated record
Abdelmoula Namil
Also filed as: NAMIL ABDELMOULA
8 granted patents·4 pending applications·58 citations·filing 1994–2012
84Inventor score
Top patents by PatentIndex Score
12 records- 0180US6200990B1Neuroprotective agents having antioxidant and NMDA antagonist activityALCON LAB INC·Filed 1999·Granted Mar 13, 2001·25 cites·18 claims
- 0273US7071225B2Arylaminopropane analogues and their use for the treatment of glaucomaALCON INC·Filed 2003·Granted Jul 4, 2006·7 cites·13 claims
- 0373US5925673ABenzofurans and benzopyrans as cytoprotective agentsALCON LAB INC·Filed 1997·Granted Jul 20, 1999·17 cites·39 claims
- 0454US5464831AThienothiadiazine sulfonamides useful as carbonic anhydrase inhibitorsALCON LAB INC·Filed 1994·Granted Nov 7, 1995·5 cites·6 claims
- 0552US2006083774A1Neurophilin ligands for treating ocular conditionsALCON INC·Filed 2005·Application pending·0 cites
- 0651US7396856B2Benzopyran analogs and their use for the treatment of glaucomaALCON INC·Filed 2005·Granted Jul 8, 2008·0 cites·9 claims
- 0745US2013116219A1Antimicrobial carboline compoundsALCON RES LTD·Filed 2012·Application pending·0 cites
- 0843US2007072920A1Phenylethylamine analogs and their use for treating glaucomaALCON INC·Filed 2006·Application pending·0 cites
- 0941US5681834AHeterocyclic sulfonamidesALCON LAB INC·Filed 1995·Granted Oct 28, 1997·2 cites·21 claims
- 1039US8252793B2Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucomaCOMBRINK KEITH D·Filed 2011·Granted Aug 28, 2012·0 cites·7 claims
- 1139US2012283260A1Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucomaCOMBRINK KEITH D·Filed 2012·Application pending·0 cites
- 1231US5510347AThienothiadiazine sulfonamides useful as carbonic anhydrase inhibitorsALCON LAB INC·Filed 1994·Granted Apr 23, 1996·2 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Abdelmoula Namil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →